Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Li Hsun Chang (Contributor)
Jing-Ping Liou (Creator)
Mei-Jung Lai (Contributor)
Chao-Di Chang (Contributor)
Huang Ju Tu (Contributor)
Min Wu Chao (Contributor)
Shiow-Lin Pan (Contributor)
Yi Ying Chen (Creator)
Che Ming Teng (Contributor)

資料集

Description

Table S1. IC50 of MPT0E028 and SAHA in pancreatic cell lines. AsPC-1, PANC-1, and BxPC-3 cells were treated with different concentrations of MPT0E028 or SAHA for 72â h. IC50 (the half maximal inhibitory concentration) was determined by MTT assay. (DOCX 12 kb)

可用日期	2019
發行者	Figshare

DOI
10.6084/m9.figshare.8202902.v1

存取資料集

Creative Commons Attribution 4.0 International

1 文章

Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. W., Chang, L. H., Tu, H. J., Chang, C. D., Lai, M. J., Chen, Y. Y., Liou, J. P., Teng, C. M. & Pan, S. L., 5月 29 2019, 於: Clinical Epigenetics. 11, 1, p. 85 85.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
26 引文斯高帕斯（Scopus）

引用此

Chang, L. (Contributor), Liou, J. (Creator), Lai, M. (Contributor), Chang, C. (Contributor), Tu, H. (Contributor), Chao, M. (Contributor), Pan, S. (Contributor), Chen, Y. (Creator), Teng, C. (Contributor) (2019). Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Figshare. 10.6084/m9.figshare.8202902.v1

Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Description

DOI

存取資料集

研究成果

Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

引用此